The patient presented to the clinic with intermittent headache detected, moderate encephalopathy observed, sudden hepatomegaly condition. Diagnostic workup revealed gene variant W748S. Treatment was initiated accordingly.
A medical history of history of episodic mental deterioration, hepatomegaly condition, presence of acute myopathy was documented. Genetic analysis confirmed gene variant R853W and G737R. Supportive care and follow-up were recommended.
The patient presented to the clinic with diagnosed with chronic abnormal cerebellum morphology, history of progressive myopathy. Diagnostic workup revealed gene variant A467T and W748S. Treatment was initiated accordingly.
A medical history of chronic elevated circulating creatine kinase concentration observed, severe headache manifestation was documented. Genetic analysis confirmed gene variant p.Arg627Gln and p.Arg852Cys. Supportive care and follow-up were recommended.
Initial symptoms included moderate abnormality of vision detected, chronic vomiting observed, presence of episodic encephalopathy. Subsequent investigations showed gene variant T251I/P587L and R807C. Management involved both pharmacological and rehabilitative approaches.
The individual was admitted with complaints of progressive headache manifestation. Laboratory evaluations detected gene variant W748S and 15q26 118 kb deletion involving POLG1 gene and FANCI gene. Clinical monitoring is ongoing.
Initial symptoms included progressive abnormality of vision observed, clinical signs of moderate vomiting, acute headache condition, sudden mental deterioration symptoms. Subsequent investigations showed gene variant c.752C>T (p.T251I) and c.2542G>A (p.G848S). Management involved both pharmacological and rehabilitative approaches.
Initial symptoms included clinical signs of progressive abnormal cerebellum morphology. Subsequent investigations showed gene variant c.1399G>A p.Ala467Thr and c.2542G>A p.Gly848Ser. Management involved both pharmacological and rehabilitative approaches.
Initial symptoms included moderate mental deterioration symptoms, episodic failure to thrive symptoms. Subsequent investigations showed . Management involved both pharmacological and rehabilitative approaches.
The patient presented to the clinic with presence of mild failure to thrive. Diagnostic workup revealed gene variant c911T > G (p. L304R) and 3240-3242 duplication (pR1081dup). Treatment was initiated accordingly.
The patient presented to the clinic with diagnosed with chronic headache, clinical signs of chronic vomiting, acute abnormal cerebellum morphology detected. Diagnostic workup revealed gene variant c.1535A>T p.K512M. Treatment was initiated accordingly.
The patient presented to the clinic with history of moderate abnormal cerebellum morphology, clinical signs of moderate vomiting. Diagnostic workup revealed gene variant c.2243G>C. Treatment was initiated accordingly.
Initial symptoms included sudden abnormal cerebellum morphology observed. Subsequent investigations showed gene variant c.1399G>A p.Ala467Thr and c.3626_3629dupGATA. Management involved both pharmacological and rehabilitative approaches.
The patient presented to the clinic with progressive myopathy symptoms, failure to thrive symptoms, persistent headache detected. Diagnostic workup revealed gene variant p.Arg953Cys. Treatment was initiated accordingly.
A medical history of sudden headache, diagnosed with chronic abnormality of vision, intermittent myopathy detected was documented. Genetic analysis confirmed gene variant c.1288A>T and c.2752T>C. Supportive care and follow-up were recommended.
Upon examination, elevated circulating creatine kinase concentration detected, mild abnormality of vision condition, mental deterioration, presence of mild encephalopathy were noted. Further imaging and laboratory tests identified gene variant p.A467T (c.1399G>A) and 4740 bp deletion (87,662,161 to 87,666,900 or c.2426 + 77 to c.3483 − 390) in the long arm of chromosome 15, spanning intron 14 to intron 21 of the POLG gene. The patient was started on a tailored therapeutic plan.
The patient presented to the clinic with sudden encephalopathy observed, persistent abnormal cerebellum morphology manifestation, moderate hepatomegaly symptoms. Diagnostic workup revealed gene variant c.1535A>T p.K512M. Treatment was initiated accordingly.
Upon examination, clinical signs of moderate mental deterioration, encephalopathy symptoms were noted. Further imaging and laboratory tests identified gene variant c. 2243G>C (p. W748S). The patient was started on a tailored therapeutic plan.
The patient presented to the clinic with progressive mental deterioration condition, severe abnormality of vision detected, episodic encephalopathy observed, moderate hepatomegaly detected. Diagnostic workup revealed gene variant p.A467T and c.2157+5_6GC>AG. Treatment was initiated accordingly.
The patient presented to the clinic with history of episodic abnormality of vision, moderate failure to thrive symptoms, history of persistent hepatomegaly. Diagnostic workup revealed gene variant c. 2243G>C (p. W748S). Treatment was initiated accordingly.
The individual was admitted with complaints of chronic myopathy, clinical signs of failure to thrive, intermittent abnormality of vision detected. Laboratory evaluations detected . Clinical monitoring is ongoing.
A medical history of episodic headache manifestation, history of intermittent myopathy, sudden mental deterioration observed, presence of progressive failure to thrive was documented. Genetic analysis confirmed gene variant c.752C>T (p.T251I) and c.2542G>A (p.G848S). Supportive care and follow-up were recommended.
Initial symptoms included acute hepatomegaly symptoms. Subsequent investigations showed gene variant A467T. Management involved both pharmacological and rehabilitative approaches.
Initial symptoms included mental deterioration observed, mild abnormality of vision condition, chronic failure to thrive, mild elevated circulating creatine kinase concentration. Subsequent investigations showed gene variant W748S. Management involved both pharmacological and rehabilitative approaches.
The patient presented to the clinic with chronic myopathy, history of intermittent elevated circulating creatine kinase concentration, diagnosed with episodic abnormality of vision. Diagnostic workup revealed gene variant c.1156C>T p.R386C and c.2794C>T p.H932Y. Treatment was initiated accordingly.
The individual was admitted with complaints of intermittent abnormality of vision detected. Laboratory evaluations detected gene variant c.679C>T p.R227W and c.2542G>A p.G848S. Clinical monitoring is ongoing.
The patient presented to the clinic with severe failure to thrive observed, persistent abnormal cerebellum morphology condition, clinical signs of moderate abnormality of vision, presence of sudden encephalopathy. Diagnostic workup revealed gene variant W748S. Treatment was initiated accordingly.
Upon examination, abnormal cerebellum morphology, moderate encephalopathy, presence of moderate mental deterioration, failure to thrive symptoms were noted. Further imaging and laboratory tests identified gene variant c.3286C>T (p.Arg1096Cys). The patient was started on a tailored therapeutic plan.
Upon examination, diagnosed with progressive failure to thrive, elevated circulating creatine kinase concentration symptoms, episodic myopathy manifestation were noted. Further imaging and laboratory tests identified gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). The patient was started on a tailored therapeutic plan.
Upon examination, mild vomiting observed, intermittent abnormality of vision observed were noted. Further imaging and laboratory tests identified gene variant 1399G>A A467T and 3573G>T K1191N. The patient was started on a tailored therapeutic plan.
Initial symptoms included presence of moderate headache, severe failure to thrive condition, episodic hepatomegaly manifestation. Subsequent investigations showed gene variant c.752C>T p.T251I and c.1760C>T p.P587L. Management involved both pharmacological and rehabilitative approaches.
Initial symptoms included diagnosed with acute abnormal cerebellum morphology, persistent myopathy observed, sudden hepatomegaly detected. Subsequent investigations showed gene variant c.1288A>T and c.2752T>C. Management involved both pharmacological and rehabilitative approaches.
A medical history of persistent abnormality of vision symptoms, clinical signs of severe hepatomegaly was documented. Genetic analysis confirmed gene variant c.1288A>T and c.2752T>C. Supportive care and follow-up were recommended.
The individual was admitted with complaints of clinical signs of intermittent failure to thrive, presence of episodic abnormality of vision. Laboratory evaluations detected gene variant W748S. Clinical monitoring is ongoing.
The individual was admitted with complaints of episodic hepatomegaly symptoms, progressive vomiting detected. Laboratory evaluations detected gene variant A467T and W748S. Clinical monitoring is ongoing.
A medical history of diagnosed with persistent abnormality of vision was documented. Genetic analysis confirmed gene variant C752T (T251I) and C1760T (P587L). Supportive care and follow-up were recommended.
Upon examination, history of abnormality of vision were noted. Further imaging and laboratory tests identified gene variant W748S and c.3643+2T>C. The patient was started on a tailored therapeutic plan.
Upon examination, clinical signs of intermittent headache, myopathy manifestation, chronic abnormality of vision condition were noted. Further imaging and laboratory tests identified gene variant c3239G>C p.Ser1080Thr. The patient was started on a tailored therapeutic plan.
The individual was admitted with complaints of chronic headache symptoms, diagnosed with mild vomiting, mild failure to thrive, acute hepatomegaly. Laboratory evaluations detected gene variant c.2243G>C. Clinical monitoring is ongoing.
Upon examination, progressive myopathy condition, severe mental deterioration manifestation, clinical signs of severe vomiting, chronic failure to thrive condition were noted. Further imaging and laboratory tests identified gene variant p.A467T and c.2157+5_6GC>AG. The patient was started on a tailored therapeutic plan.
Initial symptoms included mild abnormality of vision detected, mild hepatomegaly observed. Subsequent investigations showed gene variant A467T. Management involved both pharmacological and rehabilitative approaches.
A medical history of chronic encephalopathy manifestation was documented. Genetic analysis confirmed gene variant W748S. Supportive care and follow-up were recommended.
A medical history of episodic vomiting, sudden myopathy, presence of intermittent mental deterioration, diagnosed with headache was documented. Genetic analysis confirmed gene variant c.3643+1G>A and c.2396C>A (p.S799Y). Supportive care and follow-up were recommended.
Upon examination, history of failure to thrive were noted. Further imaging and laboratory tests identified gene variant A467T. The patient was started on a tailored therapeutic plan.
The patient presented to the clinic with diagnosed with severe abnormal cerebellum morphology, acute headache. Diagnostic workup revealed gene variant W748S. Treatment was initiated accordingly.
Initial symptoms included history of mild headache, diagnosed with sudden abnormal cerebellum morphology, diagnosed with severe vomiting, chronic failure to thrive detected. Subsequent investigations showed gene variant p.W748S and p.T914P. Management involved both pharmacological and rehabilitative approaches.
Initial symptoms included acute elevated circulating creatine kinase concentration symptoms, clinical signs of acute mental deterioration, clinical signs of chronic abnormal cerebellum morphology. Subsequent investigations showed gene variant R853W and G737R. Management involved both pharmacological and rehabilitative approaches.
Initial symptoms included abnormality of vision observed, history of persistent abnormal cerebellum morphology, persistent elevated circulating creatine kinase concentration symptoms. Subsequent investigations showed gene variant c.752C>T (p.Thr251Ile) and c.1760C>T (p.Pro587Leu). Management involved both pharmacological and rehabilitative approaches.
A medical history of mild headache condition, episodic encephalopathy observed, elevated circulating creatine kinase concentration observed, episodic vomiting manifestation was documented. Genetic analysis confirmed gene variant W748S. Supportive care and follow-up were recommended.
The individual was admitted with complaints of history of episodic encephalopathy. Laboratory evaluations detected gene variant c.2554C>T (p.R852C) and c.32G>A (p.G11D). Clinical monitoring is ongoing.
The patient presented to the clinic with diagnosed with mild vomiting, chronic abnormal cerebellum morphology condition. Diagnostic workup revealed gene variant c911T > G (p. L304R) and 3240-3242 duplication (pR1081dup). Treatment was initiated accordingly.
Upon examination, moderate vomiting symptoms, severe headache manifestation, diagnosed with chronic hepatomegaly were noted. Further imaging and laboratory tests identified gene variant A467T. The patient was started on a tailored therapeutic plan.
The patient presented to the clinic with chronic abnormality of vision, acute mental deterioration condition, severe myopathy observed. Diagnostic workup revealed gene variant c.1399G>A p.Ala467Thr and c.3626_3629dupGATA. Treatment was initiated accordingly.
The individual was admitted with complaints of intermittent abnormality of vision, moderate abnormal cerebellum morphology, chronic elevated circulating creatine kinase concentration symptoms. Laboratory evaluations detected gene variant A467T. Clinical monitoring is ongoing.
The individual was admitted with complaints of presence of severe encephalopathy, clinical signs of progressive vomiting. Laboratory evaluations detected gene variant (c.2542G > A) p.G848S and (c.1399G > A) p.A467T. Clinical monitoring is ongoing.
Initial symptoms included sudden vomiting condition, chronic mental deterioration detected, diagnosed with mild encephalopathy. Subsequent investigations showed gene variant 1399G >A A467T and 2243G >C W748S. Management involved both pharmacological and rehabilitative approaches.
Initial symptoms included clinical signs of vomiting. Subsequent investigations showed gene variant c.3311C>G (p.S1104C) and c.2542G>A (p.G848S). Management involved both pharmacological and rehabilitative approaches.
The patient presented to the clinic with intermittent elevated circulating creatine kinase concentration symptoms, episodic failure to thrive symptoms, mild encephalopathy symptoms, severe vomiting detected. Diagnostic workup revealed gene variant c.1156C>T p.R386C and c.2794C>T p.H932Y. Treatment was initiated accordingly.
The individual was admitted with complaints of clinical signs of severe headache, mild mental deterioration, diagnosed with acute hepatomegaly. Laboratory evaluations detected gene variant W748S. Clinical monitoring is ongoing.
Upon examination, acute vomiting symptoms, chronic encephalopathy observed were noted. Further imaging and laboratory tests identified gene variant c.752C>T (p.T251I) and c.2542G>A (p.G848S). The patient was started on a tailored therapeutic plan.
The patient presented to the clinic with diagnosed with failure to thrive, presence of progressive abnormality of vision, acute hepatomegaly symptoms, history of moderate mental deterioration. Diagnostic workup revealed gene variant W748S and 15q26 118 kb deletion involving POLG1 gene and FANCI gene. Treatment was initiated accordingly.
The individual was admitted with complaints of presence of severe failure to thrive, history of intermittent myopathy. Laboratory evaluations detected gene variant W748S and c.3643+2T>C. Clinical monitoring is ongoing.
Upon examination, acute myopathy symptoms were noted. Further imaging and laboratory tests identified gene variant c.752C>T (p.T251I) and c.3572A>G (p.K1191R). The patient was started on a tailored therapeutic plan.
The individual was admitted with complaints of clinical signs of persistent myopathy, presence of intermittent mental deterioration, diagnosed with sudden abnormal cerebellum morphology. Laboratory evaluations detected gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). Clinical monitoring is ongoing.
Upon examination, mild hepatomegaly detected, sudden vomiting manifestation were noted. Further imaging and laboratory tests identified gene variant p.A467T and c.2157+5_6GC>AG. The patient was started on a tailored therapeutic plan.
A medical history of diagnosed with persistent failure to thrive, severe encephalopathy detected was documented. Genetic analysis confirmed gene variant c.752C>T p.T251I and c.1760C>T p.P587L. Supportive care and follow-up were recommended.
The patient presented to the clinic with presence of episodic headache. Diagnostic workup revealed gene variant p.A467T (c.1399G>A) and 4740 bp deletion (87,662,161 to 87,666,900 or c.2426 + 77 to c.3483 − 390) in the long arm of chromosome 15, spanning intron 14 to intron 21 of the POLG gene. Treatment was initiated accordingly.
Initial symptoms included mild failure to thrive observed. Subsequent investigations showed gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). Management involved both pharmacological and rehabilitative approaches.
The individual was admitted with complaints of presence of episodic failure to thrive, acute headache observed, mild abnormality of vision. Laboratory evaluations detected . Clinical monitoring is ongoing.
The individual was admitted with complaints of clinical signs of mild failure to thrive, intermittent vomiting detected. Laboratory evaluations detected gene variant p.Arg953Cys. Clinical monitoring is ongoing.
A medical history of history of intermittent headache, clinical signs of episodic mental deterioration, severe hepatomegaly observed was documented. Genetic analysis confirmed gene variant c.752C>T (p.Thr251Ile) and c.1760C>T (p.Pro587Leu). Supportive care and follow-up were recommended.
Upon examination, diagnosed with mild myopathy, progressive encephalopathy manifestation, acute abnormal cerebellum morphology observed were noted. Further imaging and laboratory tests identified gene variant A467T and W748S. The patient was started on a tailored therapeutic plan.
Upon examination, clinical signs of severe myopathy were noted. Further imaging and laboratory tests identified gene variant W748S and c.3643+2T>C. The patient was started on a tailored therapeutic plan.
A medical history of intermittent failure to thrive observed, headache, progressive abnormal cerebellum morphology symptoms, chronic encephalopathy symptoms was documented. Genetic analysis confirmed gene variant Tyr955Cys. Supportive care and follow-up were recommended.
Initial symptoms included progressive failure to thrive condition. Subsequent investigations showed gene variant R853W and G737R. Management involved both pharmacological and rehabilitative approaches.
The individual was admitted with complaints of presence of persistent headache, progressive encephalopathy manifestation, progressive abnormality of vision observed, acute abnormal cerebellum morphology. Laboratory evaluations detected gene variant c.2243G>C p.Trp748Ser. Clinical monitoring is ongoing.
The individual was admitted with complaints of persistent myopathy condition, severe vomiting symptoms. Laboratory evaluations detected gene variant p.A467T and c.2157+5_6GC>AG. Clinical monitoring is ongoing.
The patient presented to the clinic with persistent failure to thrive observed, mild headache detected. Diagnostic workup revealed gene variant A467T and W748S. Treatment was initiated accordingly.
Upon examination, persistent abnormal cerebellum morphology observed, diagnosed with sudden hepatomegaly were noted. Further imaging and laboratory tests identified gene variant A467T and W748S. The patient was started on a tailored therapeutic plan.
The patient presented to the clinic with intermittent failure to thrive observed. Diagnostic workup revealed gene variant A467T and W748S. Treatment was initiated accordingly.
A medical history of vomiting symptoms was documented. Genetic analysis confirmed gene variant c.1399G>A (p.A467T) and c.3285C>G (p.S1095R). Supportive care and follow-up were recommended.
The individual was admitted with complaints of intermittent myopathy detected, history of episodic mental deterioration. Laboratory evaluations detected gene variant A467T. Clinical monitoring is ongoing.
A medical history of intermittent encephalopathy observed, presence of acute failure to thrive was documented. Genetic analysis confirmed gene variant c.679C>T p.R227W and c.2542G>A p.G848S. Supportive care and follow-up were recommended.
The patient presented to the clinic with intermittent abnormality of vision, acute abnormal cerebellum morphology condition, intermittent failure to thrive manifestation, moderate hepatomegaly condition. Diagnostic workup revealed gene variant c.752C>T p.T251I and c.1760C>T p.P587L. Treatment was initiated accordingly.
The patient presented to the clinic with intermittent encephalopathy symptoms, clinical signs of acute elevated circulating creatine kinase concentration. Diagnostic workup revealed gene variant W748S. Treatment was initiated accordingly.
The patient presented to the clinic with moderate abnormality of vision detected. Diagnostic workup revealed gene variant R853W and G737R. Treatment was initiated accordingly.
The individual was admitted with complaints of acute mental deterioration condition, severe myopathy. Laboratory evaluations detected gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). Clinical monitoring is ongoing.
Initial symptoms included abnormality of vision manifestation. Subsequent investigations showed gene variant W748S and 15q26 118 kb deletion involving POLG1 gene and FANCI gene. Management involved both pharmacological and rehabilitative approaches.
The individual was admitted with complaints of acute abnormal cerebellum morphology observed. Laboratory evaluations detected gene variant c.3643+1G>A and c.2396C>A (p.S799Y). Clinical monitoring is ongoing.
A medical history of severe elevated circulating creatine kinase concentration observed was documented. Genetic analysis confirmed gene variant c.2554C>T (p.R852C) and c.32G>A (p.G11D). Supportive care and follow-up were recommended.
Upon examination, myopathy manifestation were noted. Further imaging and laboratory tests identified gene variant 1399G>A A467T and 3573G>T K1191N. The patient was started on a tailored therapeutic plan.
Upon examination, severe abnormality of vision condition, diagnosed with persistent hepatomegaly were noted. Further imaging and laboratory tests identified gene variant c.752C>T (p.T251I) and c.2542G>A (p.G848S). The patient was started on a tailored therapeutic plan.
Initial symptoms included failure to thrive observed, history of persistent vomiting, episodic mental deterioration detected, chronic headache symptoms. Subsequent investigations showed gene variant p.Arg953Cys. Management involved both pharmacological and rehabilitative approaches.
The patient presented to the clinic with episodic myopathy manifestation, presence of chronic encephalopathy, history of hepatomegaly, persistent abnormality of vision. Diagnostic workup revealed gene variant A467T and W748S. Treatment was initiated accordingly.
The patient presented to the clinic with acute encephalopathy manifestation, presence of persistent vomiting, severe failure to thrive manifestation, diagnosed with chronic hepatomegaly. Diagnostic workup revealed gene variant 1868T>G  L623W and 2263A>G K755E. Treatment was initiated accordingly.
Initial symptoms included history of episodic mental deterioration, moderate myopathy condition, progressive encephalopathy detected. Subsequent investigations showed gene variant A467T. Management involved both pharmacological and rehabilitative approaches.
The patient presented to the clinic with history of intermittent hepatomegaly, episodic headache symptoms, episodic elevated circulating creatine kinase concentration. Diagnostic workup revealed gene variant c.2243G>C. Treatment was initiated accordingly.
Upon examination, history of intermittent mental deterioration were noted. Further imaging and laboratory tests identified gene variant A467T. The patient was started on a tailored therapeutic plan.
The individual was admitted with complaints of progressive abnormal cerebellum morphology observed. Laboratory evaluations detected gene variant c.3311C>G (p.S1104C) and c.2542G>A (p.G848S). Clinical monitoring is ongoing.
The individual was admitted with complaints of history of episodic encephalopathy, diagnosed with sudden abnormality of vision, chronic failure to thrive detected. Laboratory evaluations detected gene variant c.1399G>A p.Ala467Thr and c.2542G>A p.Gly848Ser. Clinical monitoring is ongoing.
The individual was admitted with complaints of persistent failure to thrive symptoms, presence of progressive headache, progressive encephalopathy observed, mild abnormality of vision symptoms. Laboratory evaluations detected gene variant c.1288A>T p.M430L and c.2752T>C p.W918R. Clinical monitoring is ongoing.
Initial symptoms included progressive abnormal cerebellum morphology observed, progressive abnormality of vision, persistent encephalopathy condition, headache observed. Subsequent investigations showed gene variant R853W and G737R. Management involved both pharmacological and rehabilitative approaches.
Upon examination, moderate failure to thrive manifestation, clinical signs of progressive headache, presence of mild encephalopathy, progressive abnormality of vision were noted. Further imaging and laboratory tests identified gene variant A467T and W748S. The patient was started on a tailored therapeutic plan.
A medical history of progressive abnormal cerebellum morphology detected, history of sudden headache, moderate mental deterioration, moderate abnormality of vision detected was documented. Genetic analysis confirmed gene variant p.Arg627Gln and p.Arg852Cys. Supportive care and follow-up were recommended.
The patient presented to the clinic with episodic abnormal cerebellum morphology detected, diagnosed with vomiting. Diagnostic workup revealed gene variant C752T (T251I) and C1760T (P587L). Treatment was initiated accordingly.
The patient presented to the clinic with diagnosed with episodic abnormality of vision, clinical signs of chronic elevated circulating creatine kinase concentration, mild encephalopathy observed. Diagnostic workup revealed gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). Treatment was initiated accordingly.
The patient presented to the clinic with sudden vomiting manifestation, history of chronic abnormal cerebellum morphology. Diagnostic workup revealed . Treatment was initiated accordingly.
The individual was admitted with complaints of moderate vomiting symptoms, diagnosed with chronic encephalopathy, failure to thrive, clinical signs of acute abnormal cerebellum morphology. Laboratory evaluations detected gene variant C752T (T251I) and C1760T (P587L). Clinical monitoring is ongoing.
Upon examination, history of mild encephalopathy, episodic hepatomegaly condition, acute abnormal cerebellum morphology symptoms, intermittent failure to thrive were noted. Further imaging and laboratory tests identified gene variant A467T and W748S. The patient was started on a tailored therapeutic plan.
Upon examination, presence of severe hepatomegaly, headache manifestation, acute failure to thrive detected, episodic mental deterioration were noted. Further imaging and laboratory tests identified gene variant c.1535A>T p.K512M. The patient was started on a tailored therapeutic plan.
The patient presented to the clinic with chronic failure to thrive, clinical signs of episodic mental deterioration. Diagnostic workup revealed gene variant p.A467T and c.2157+5_6GC>AG. Treatment was initiated accordingly.
The individual was admitted with complaints of presence of episodic abnormality of vision, persistent vomiting condition. Laboratory evaluations detected gene variant c.1288A>T and c.2752T>C. Clinical monitoring is ongoing.
A medical history of diagnosed with intermittent encephalopathy, mild headache was documented. Genetic analysis confirmed gene variant c.2993C>T p.998S>L and c.3550G>C p.1184D>H. Supportive care and follow-up were recommended.
The individual was admitted with complaints of chronic hepatomegaly symptoms, episodic abnormal cerebellum morphology symptoms, chronic failure to thrive symptoms, acute mental deterioration observed. Laboratory evaluations detected gene variant W748S and 15q26 118 kb deletion involving POLG1 gene and FANCI gene. Clinical monitoring is ongoing.
A medical history of acute myopathy, episodic abnormality of vision symptoms, acute encephalopathy detected, persistent abnormal cerebellum morphology was documented. Genetic analysis confirmed . Supportive care and follow-up were recommended.
Upon examination, clinical signs of mild hepatomegaly, chronic myopathy manifestation were noted. Further imaging and laboratory tests identified gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). The patient was started on a tailored therapeutic plan.
The patient presented to the clinic with presence of persistent hepatomegaly, clinical signs of sudden failure to thrive, clinical signs of progressive headache. Diagnostic workup revealed gene variant p.W748S and p.T914P. Treatment was initiated accordingly.
Upon examination, diagnosed with severe elevated circulating creatine kinase concentration, chronic encephalopathy condition were noted. Further imaging and laboratory tests identified gene variant W748S. The patient was started on a tailored therapeutic plan.
Initial symptoms included clinical signs of sudden headache, elevated circulating creatine kinase concentration detected, sudden abnormal cerebellum morphology. Subsequent investigations showed gene variant W748S and 15q26 118 kb deletion involving POLG1 gene and FANCI gene. Management involved both pharmacological and rehabilitative approaches.
Initial symptoms included persistent headache. Subsequent investigations showed . Management involved both pharmacological and rehabilitative approaches.
The individual was admitted with complaints of episodic elevated circulating creatine kinase concentration symptoms, diagnosed with intermittent failure to thrive, presence of persistent mental deterioration. Laboratory evaluations detected gene variant c.752C>T (p.Thr251Ile) and c.1760C>T (p.Pro587Leu). Clinical monitoring is ongoing.
Initial symptoms included persistent hepatomegaly manifestation, history of chronic abnormal cerebellum morphology, episodic myopathy condition. Subsequent investigations showed gene variant c.1399G>A p.Ala467Thr and c.3626_3629dupGATA. Management involved both pharmacological and rehabilitative approaches.
A medical history of acute encephalopathy observed, chronic vomiting symptoms was documented. Genetic analysis confirmed gene variant c3239G>C p.Ser1080Thr. Supportive care and follow-up were recommended.
A medical history of chronic encephalopathy manifestation was documented. Genetic analysis confirmed gene variant (c.2542G > A) p.G848S and (c.1399G > A) p.A467T. Supportive care and follow-up were recommended.
Initial symptoms included severe failure to thrive observed, chronic mental deterioration, clinical signs of acute hepatomegaly. Subsequent investigations showed gene variant c.1399G>A p.Ala467Thr and c.2542G>A p.Gly848Ser. Management involved both pharmacological and rehabilitative approaches.
Initial symptoms included clinical signs of abnormality of vision. Subsequent investigations showed gene variant R853W and G737R. Management involved both pharmacological and rehabilitative approaches.
Upon examination, history of mild failure to thrive, diagnosed with persistent hepatomegaly, presence of sudden vomiting, moderate headache observed were noted. Further imaging and laboratory tests identified gene variant T251I/P587L and R807C. The patient was started on a tailored therapeutic plan.
The individual was admitted with complaints of mild mental deterioration manifestation. Laboratory evaluations detected gene variant c.1288A>T and c.2752T>C. Clinical monitoring is ongoing.
A medical history of episodic abnormality of vision, clinical signs of chronic headache, presence of persistent elevated circulating creatine kinase concentration was documented. Genetic analysis confirmed gene variant A467T and W748S. Supportive care and follow-up were recommended.
The patient presented to the clinic with acute abnormal cerebellum morphology. Diagnostic workup revealed gene variant W748S and c.3643+2T>C. Treatment was initiated accordingly.
The patient presented to the clinic with progressive myopathy manifestation, history of progressive abnormality of vision. Diagnostic workup revealed gene variant c.2993C>T p.998S>L and c.3550G>C p.1184D>H. Treatment was initiated accordingly.
The individual was admitted with complaints of severe abnormal cerebellum morphology observed, episodic myopathy, acute hepatomegaly, intermittent vomiting. Laboratory evaluations detected gene variant c.1535A>T p.K512M. Clinical monitoring is ongoing.
The individual was admitted with complaints of acute abnormality of vision manifestation. Laboratory evaluations detected gene variant 1868T>G  L623W and 2263A>G K755E. Clinical monitoring is ongoing.
A medical history of persistent elevated circulating creatine kinase concentration was documented. Genetic analysis confirmed gene variant c.2554C>T (p.R852C) and c.32G>A (p.G11D). Supportive care and follow-up were recommended.
The patient presented to the clinic with diagnosed with chronic elevated circulating creatine kinase concentration, clinical signs of persistent myopathy, diagnosed with mild failure to thrive. Diagnostic workup revealed gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). Treatment was initiated accordingly.
The individual was admitted with complaints of presence of progressive encephalopathy, presence of hepatomegaly, headache observed, episodic vomiting detected. Laboratory evaluations detected gene variant c.1288A>T and c.2752T>C. Clinical monitoring is ongoing.
A medical history of moderate encephalopathy symptoms, mild headache was documented. Genetic analysis confirmed . Supportive care and follow-up were recommended.
Initial symptoms included clinical signs of acute mental deterioration, persistent abnormality of vision observed. Subsequent investigations showed gene variant p.Arg627Gln and p.Arg852Cys. Management involved both pharmacological and rehabilitative approaches.
The individual was admitted with complaints of intermittent abnormal cerebellum morphology condition. Laboratory evaluations detected gene variant 1399G→A (A467T). Clinical monitoring is ongoing.
The patient presented to the clinic with clinical signs of persistent headache, sudden hepatomegaly observed. Diagnostic workup revealed gene variant 1399G >A A467T and 2243G >C W748S. Treatment was initiated accordingly.
The patient presented to the clinic with diagnosed with persistent failure to thrive, presence of progressive vomiting. Diagnostic workup revealed gene variant 1399G>A A467T and 3573G>T K1191N. Treatment was initiated accordingly.
The patient presented to the clinic with clinical signs of acute encephalopathy, episodic hepatomegaly, presence of intermittent vomiting. Diagnostic workup revealed gene variant T251I/P587L and R807C. Treatment was initiated accordingly.
A medical history of history of intermittent headache was documented. Genetic analysis confirmed . Supportive care and follow-up were recommended.
Initial symptoms included sudden failure to thrive observed, history of episodic vomiting. Subsequent investigations showed gene variant c.2993C>T p.998S>L and c.3550G>C p.1184D>H. Management involved both pharmacological and rehabilitative approaches.
Upon examination, presence of moderate elevated circulating creatine kinase concentration were noted. Further imaging and laboratory tests identified gene variant c.679C>T p.R227W and c.2542G>A p.G848S. The patient was started on a tailored therapeutic plan.
A medical history of mental deterioration manifestation, vomiting manifestation, progressive abnormal cerebellum morphology, chronic hepatomegaly observed was documented. Genetic analysis confirmed gene variant c.1288A>T and c.2752T>C. Supportive care and follow-up were recommended.
Upon examination, history of chronic myopathy, clinical signs of severe headache, history of sudden hepatomegaly were noted. Further imaging and laboratory tests identified gene variant c.1535A>T p.K512M. The patient was started on a tailored therapeutic plan.
The individual was admitted with complaints of history of persistent headache, history of intermittent vomiting, encephalopathy observed, severe abnormality of vision condition. Laboratory evaluations detected gene variant c3239G>C p.Ser1080Thr. Clinical monitoring is ongoing.
Upon examination, presence of sudden vomiting were noted. Further imaging and laboratory tests identified gene variant 1399G→A (A467T). The patient was started on a tailored therapeutic plan.
The patient presented to the clinic with failure to thrive manifestation, clinical signs of mental deterioration, vomiting observed, history of episodic abnormality of vision. Diagnostic workup revealed gene variant c.752C>T p.T251I and c.1760C>T p.P587L. Treatment was initiated accordingly.
A medical history of episodic vomiting condition, presence of moderate mental deterioration was documented. Genetic analysis confirmed gene variant A467T and W748S. Supportive care and follow-up were recommended.
Upon examination, progressive hepatomegaly condition, diagnosed with chronic abnormality of vision, presence of moderate headache were noted. Further imaging and laboratory tests identified gene variant c.1288A>T and c.2752T>C. The patient was started on a tailored therapeutic plan.
The patient presented to the clinic with acute failure to thrive condition. Diagnostic workup revealed gene variant c.2584G>A p.A862T and c.830A>T p.H277L. Treatment was initiated accordingly.
A medical history of history of headache, episodic myopathy observed, persistent abnormal cerebellum morphology observed, episodic abnormality of vision detected was documented. Genetic analysis confirmed gene variant p.A467T (c.1399G>A) and 4740 bp deletion (87,662,161 to 87,666,900 or c.2426 + 77 to c.3483 − 390) in the long arm of chromosome 15, spanning intron 14 to intron 21 of the POLG gene. Supportive care and follow-up were recommended.
The individual was admitted with complaints of clinical signs of mild failure to thrive, severe vomiting condition, moderate abnormality of vision detected. Laboratory evaluations detected gene variant A467T. Clinical monitoring is ongoing.
A medical history of progressive vomiting manifestation, acute mental deterioration symptoms, persistent elevated circulating creatine kinase concentration manifestation, persistent hepatomegaly observed was documented. Genetic analysis confirmed gene variant 1868T>G  L623W and 2263A>G K755E. Supportive care and follow-up were recommended.
Initial symptoms included presence of mild abnormality of vision, myopathy. Subsequent investigations showed gene variant c911T > G (p. L304R) and 3240-3242 duplication (pR1081dup). Management involved both pharmacological and rehabilitative approaches.
The individual was admitted with complaints of acute vomiting condition, history of sudden elevated circulating creatine kinase concentration, severe abnormality of vision detected. Laboratory evaluations detected gene variant c.1399G>A p.Ala467Thr and c.3626_3629dupGATA. Clinical monitoring is ongoing.
The patient presented to the clinic with presence of intermittent vomiting, history of episodic mental deterioration, progressive myopathy manifestation, history of acute abnormal cerebellum morphology. Diagnostic workup revealed gene variant p.Arg953Cys. Treatment was initiated accordingly.
The individual was admitted with complaints of chronic failure to thrive observed, acute abnormal cerebellum morphology condition, history of mild myopathy, clinical signs of progressive vomiting. Laboratory evaluations detected gene variant c.3286C>T (p.Arg1096Cys). Clinical monitoring is ongoing.
A medical history of moderate failure to thrive, history of chronic abnormality of vision, diagnosed with persistent mental deterioration, hepatomegaly condition was documented. Genetic analysis confirmed gene variant p.A467T and c.2157+5_6GC>AG. Supportive care and follow-up were recommended.
Upon examination, persistent headache symptoms, history of moderate myopathy were noted. Further imaging and laboratory tests identified . The patient was started on a tailored therapeutic plan.
The patient presented to the clinic with sudden hepatomegaly condition, progressive myopathy symptoms, diagnosed with acute vomiting, diagnosed with persistent failure to thrive. Diagnostic workup revealed gene variant c.3311C>G (p.S1104C) and c.2542G>A (p.G848S). Treatment was initiated accordingly.
Initial symptoms included diagnosed with chronic abnormality of vision, history of progressive failure to thrive, severe elevated circulating creatine kinase concentration condition. Subsequent investigations showed gene variant c.1399G>A p.Ala467Thr and c.2542G>A p.Gly848Ser. Management involved both pharmacological and rehabilitative approaches.
Upon examination, progressive failure to thrive condition, clinical signs of persistent headache, moderate mental deterioration manifestation were noted. Further imaging and laboratory tests identified gene variant c.1288A>T and c.2752T>C. The patient was started on a tailored therapeutic plan.
Initial symptoms included intermittent vomiting symptoms, episodic failure to thrive condition. Subsequent investigations showed gene variant c.2584G>A p.A862T and c.830A>T p.H277L. Management involved both pharmacological and rehabilitative approaches.
The individual was admitted with complaints of persistent abnormality of vision symptoms. Laboratory evaluations detected gene variant c.752C>T p.T251I and c.1760C>T p.P587L. Clinical monitoring is ongoing.
Upon examination, elevated circulating creatine kinase concentration condition, moderate vomiting manifestation, headache were noted. Further imaging and laboratory tests identified gene variant p.W748S and p.T914P. The patient was started on a tailored therapeutic plan.
The individual was admitted with complaints of vomiting, presence of chronic failure to thrive, diagnosed with moderate abnormality of vision, progressive headache manifestation. Laboratory evaluations detected gene variant A467T and W748S. Clinical monitoring is ongoing.
Initial symptoms included diagnosed with myopathy, chronic failure to thrive symptoms, diagnosed with severe vomiting, presence of sudden encephalopathy. Subsequent investigations showed gene variant c.752C>T (p.Thr251Ile) and c.1760C>T (p.Pro587Leu). Management involved both pharmacological and rehabilitative approaches.
The individual was admitted with complaints of history of persistent hepatomegaly, mild failure to thrive symptoms, sudden abnormality of vision manifestation, presence of moderate myopathy. Laboratory evaluations detected gene variant c.2243G>C p.Trp748Ser. Clinical monitoring is ongoing.
The patient presented to the clinic with clinical signs of chronic vomiting. Diagnostic workup revealed gene variant c. 2243G>C (p. W748S). Treatment was initiated accordingly.
A medical history of chronic elevated circulating creatine kinase concentration detected was documented. Genetic analysis confirmed gene variant p.W748S and p.T914P. Supportive care and follow-up were recommended.
A medical history of diagnosed with progressive elevated circulating creatine kinase concentration, moderate hepatomegaly manifestation was documented. Genetic analysis confirmed gene variant A467T. Supportive care and follow-up were recommended.
The individual was admitted with complaints of persistent abnormality of vision symptoms, episodic myopathy symptoms, episodic vomiting manifestation. Laboratory evaluations detected gene variant p.A467T (c.1399G>A) and 4740 bp deletion (87,662,161 to 87,666,900 or c.2426 + 77 to c.3483 − 390) in the long arm of chromosome 15, spanning intron 14 to intron 21 of the POLG gene. Clinical monitoring is ongoing.
The patient presented to the clinic with episodic hepatomegaly manifestation, history of mild headache, diagnosed with chronic abnormal cerebellum morphology, clinical signs of episodic myopathy. Diagnostic workup revealed gene variant p.A467T and c.2157+5_6GC>AG. Treatment was initiated accordingly.
A medical history of diagnosed with severe vomiting, history of abnormality of vision, mild failure to thrive observed was documented. Genetic analysis confirmed gene variant A467T. Supportive care and follow-up were recommended.
The patient presented to the clinic with chronic mental deterioration symptoms, history of moderate elevated circulating creatine kinase concentration. Diagnostic workup revealed gene variant c.1288A>T and c.2752T>C. Treatment was initiated accordingly.
The individual was admitted with complaints of clinical signs of persistent elevated circulating creatine kinase concentration. Laboratory evaluations detected gene variant W748S. Clinical monitoring is ongoing.
Upon examination, history of progressive mental deterioration, history of progressive abnormal cerebellum morphology, chronic vomiting observed were noted. Further imaging and laboratory tests identified gene variant (c.2542G > A) p.G848S and (c.1399G > A) p.A467T. The patient was started on a tailored therapeutic plan.
The individual was admitted with complaints of diagnosed with acute abnormality of vision. Laboratory evaluations detected gene variant W748S. Clinical monitoring is ongoing.
A medical history of intermittent elevated circulating creatine kinase concentration detected, severe mental deterioration detected, intermittent failure to thrive detected was documented. Genetic analysis confirmed gene variant c. 2243G>C (p. W748S). Supportive care and follow-up were recommended.
The individual was admitted with complaints of progressive abnormality of vision observed, elevated circulating creatine kinase concentration condition, presence of persistent vomiting. Laboratory evaluations detected . Clinical monitoring is ongoing.
A medical history of mild encephalopathy condition was documented. Genetic analysis confirmed gene variant p.A467T (c.1399G>A) and 4740 bp deletion (87,662,161 to 87,666,900 or c.2426 + 77 to c.3483 − 390) in the long arm of chromosome 15, spanning intron 14 to intron 21 of the POLG gene. Supportive care and follow-up were recommended.
A medical history of mild failure to thrive, presence of moderate vomiting, presence of chronic abnormality of vision, encephalopathy detected was documented. Genetic analysis confirmed gene variant 1399G→A (A467T). Supportive care and follow-up were recommended.
The individual was admitted with complaints of severe abnormal cerebellum morphology manifestation, clinical signs of progressive mental deterioration, history of severe abnormality of vision. Laboratory evaluations detected gene variant c.752C>T p.T251I and c.1760C>T p.P587L. Clinical monitoring is ongoing.
Initial symptoms included intermittent vomiting detected. Subsequent investigations showed gene variant A467T and W748S. Management involved both pharmacological and rehabilitative approaches.
A medical history of moderate failure to thrive symptoms was documented. Genetic analysis confirmed gene variant c.3286C>T (p.Arg1096Cys). Supportive care and follow-up were recommended.
Upon examination, sudden hepatomegaly were noted. Further imaging and laboratory tests identified gene variant c.3102delG (p.Lys1035Serfs*59) and c.3286C>T (p.Arg1096Cys). The patient was started on a tailored therapeutic plan.
A medical history of presence of moderate elevated circulating creatine kinase concentration, history of persistent abnormality of vision, presence of mild mental deterioration was documented. Genetic analysis confirmed gene variant p.W748S and p.T914P. Supportive care and follow-up were recommended.
A medical history of persistent abnormality of vision manifestation, severe headache manifestation was documented. Genetic analysis confirmed gene variant c.2993C>T p.998S>L and c.3550G>C p.1184D>H. Supportive care and follow-up were recommended.
Initial symptoms included intermittent abnormality of vision manifestation, clinical signs of moderate myopathy. Subsequent investigations showed gene variant W748S. Management involved both pharmacological and rehabilitative approaches.
The patient presented to the clinic with intermittent headache condition, severe elevated circulating creatine kinase concentration, moderate encephalopathy manifestation. Diagnostic workup revealed gene variant c.3286C>T (p.Arg1096Cys). Treatment was initiated accordingly.
The individual was admitted with complaints of diagnosed with progressive vomiting. Laboratory evaluations detected gene variant c.1399G>A (p.A467T) and c.3285C>G (p.S1095R). Clinical monitoring is ongoing.
The patient presented to the clinic with presence of sudden hepatomegaly, clinical signs of episodic elevated circulating creatine kinase concentration, moderate vomiting symptoms. Diagnostic workup revealed gene variant p.Arg953Cys. Treatment was initiated accordingly.
The individual was admitted with complaints of presence of chronic abnormality of vision, chronic hepatomegaly manifestation, presence of persistent vomiting. Laboratory evaluations detected . Clinical monitoring is ongoing.
A medical history of chronic vomiting detected, diagnosed with moderate myopathy was documented. Genetic analysis confirmed gene variant p.A467T and c.2157+5_6GC>AG. Supportive care and follow-up were recommended.
Upon examination, vomiting manifestation, sudden abnormality of vision symptoms, progressive mental deterioration detected were noted. Further imaging and laboratory tests identified gene variant c.3311C>G (p.S1104C) and c.2542G>A (p.G848S). The patient was started on a tailored therapeutic plan.
A medical history of sudden headache was documented. Genetic analysis confirmed gene variant c.2584G>A p.A862T and c.830A>T p.H277L. Supportive care and follow-up were recommended.
A medical history of presence of persistent vomiting was documented. Genetic analysis confirmed gene variant A467T and W748S. Supportive care and follow-up were recommended.
